血管パッチ市場の評価：材料タイプ・用途・エンドユーザー・地域別の機会および予測 (2017-2031年)

世界の血管パッチの市場規模は、2023年の5億768万米ドルから、2024年から2031年の予測期間中は6.97%のCAGRで推移し、2031年には8億7,012万米ドルの規模に成長すると予測されています。同市場は近年著しい成長を遂げており、今後も力強い拡大ペースを維持すると予想されています。

血管パッチは、動脈瘤、動脈狭窄、望ましくない血栓の治療に使用されるほか、心血管疾患における組織や動脈の再建にも使用されます。心臓動脈 (冠動脈バイパス) 、腎臓、脚 (大腿膝窩バイパス) 、腹部大動脈が通常の手術部位です。心血管障害の世界の有病率の増加が血管パッチ市場の成長を牽引しています。またこの側面は、ストレスレベルの変化やライフスタイルの変化を示す世界的な喫煙率の上昇によっても強化されています。高齢化による血管障害の増加、ヘルスケア施設の拡大、これらの症状に関連する治療に対する有利な償還政策、生物学的パッチの使用の増加なども市場を牽引しています。

市場成長を促進する再生医療の採用の拡大：

再生医療の利用の拡大が世界の血管パッチ市場を推進する主な要因です。血管パッチは、組織の修復と置換におけるゲームチェンジャーである再生医療の科学に不可欠です。再生医療は、組織修復のために身体に本来備わっている治癒能力を利用しようとするもので、医療における大きなパラダイムチェンジです。この方法は、心臓疾患、整形外科的損傷、外傷に関連した組織の再構築など、いくつかの病気の治療において有望な結果を示しています。血管パッチは、細胞の発生と分化を誘導する生物学的足場として機能するため、再生医療には不可欠です。これらのパッチは自然な組織再生を促進するため、多くの異なるタイプの再生治療において極めて重要です。特に心臓は再生能力が限られていることから、心臓の再生医療に多くの注目が集まっています。心筋梗塞の後、損傷した心臓組織を回復させるために、血管パッチは心臓再生手術に効果的に使用されてきました。心血管系疾患は、世界の健康問題であり、再生医療と血管パッチは、今後さらに普及すると予想されています。

当レポートでは、世界の血管パッチの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の血管パッチ市場の展望

• 市場規模・予測
• 材料タイプ別
  • 生物学的血管パッチ
  • 合成血管パッチ
• 用途別
  • 頸動脈内膜切除術
  • 大動脈瘤の開腹修復術
  • 血管バイパス手術
  • 先天性心疾患
  • 深部形成術
  • その他
• エンドユーザー別
  • 病院
  • 外来手術センター
  • 外傷ケアセンター
• 地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ
• 企業別市場シェア

第5章 世界の血管パッチ市場の展望：地域別

• 北米
• 欧州
• 南米
• アジア太平洋
• 中東・アフリカ

第6章 市場マッピング、2023年

• 素材の種類別
• アプリケーション別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長推進因子
• 成長阻害因子 (課題・制約)

第9章 規制枠組みとイノベーション

• 臨床試験
• 規制当局の承認
• イノベーション/新興技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析 (参入5社)
• 特許分析 (該当する場合)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

• Baxter International, Inc.
• LeMaitre Vascular, Inc.
• W. L. Gore & Associates, Inc.
• Getinge AB
• B. Braun Medical Ltd.
• Edwards Lifesciences Corporation
• Becton, Dickinson and Company
• Terumo Corporation
• Artivion, Inc.
• Labcor Laboratorios

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 2. Global Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 3. Global Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 4. Global Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 5. Global Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 6. Global Vascular Patches Market Share (%), By Region, 2017-2031F
• Figure 7. North America Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 8. North America Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 9. North America Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 10. North America Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 11. North America Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 12. North America Vascular Patches Market Share (%), By Country, 2017-2031F
• Figure 13. United States Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 14. United States Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 15. United States Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 16. United States Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 17. United States Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 19. Canada Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 20. Canada Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 21. Canada Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 22. Canada Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 24. Mexico Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 25. Mexico Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 26. Mexico Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 27. Mexico Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 29. Europe Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 30. Europe Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 31. Europe Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 32. Europe Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Vascular Patches Market Share (%), By Country, 2017-2031F
• Figure 34. Germany Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 35. Germany Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 36. Germany Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 37. Germany Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 38. Germany Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 39. France Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 40. France Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 41. France Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 42. France Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 43. France Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 45. Italy Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 46. Italy Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 47. Italy Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 48. Italy Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 50. United Kingdom Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 51. United Kingdom Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 52. United Kingdom Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 53. United Kingdom Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 55. Russia Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 56. Russia Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 57. Russia Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 58. Russia Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 60. Netherlands Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 61. Netherlands Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 62. Netherlands Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 63. Netherlands Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 65. Spain Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 66. Spain Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 67. Spain Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 68. Spain Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 70. Turkey Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 71. Turkey Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 72. Turkey Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 73. Turkey Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 75. Poland Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 76. Poland Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 77. Poland Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 78. Poland Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 79. South America Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 80. South America Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 81. South America Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 82. South America Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 83. South America Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 84. South America Vascular Patches Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 86. Brazil Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 87. Brazil Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 88. Brazil Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 89. Brazil Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 91. Argentina Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 92. Argentina Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 93. Argentina Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 94. Argentina Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 96. Asia-Pacific Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 97. Asia-Pacific Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 98. Asia-Pacific Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 99. Asia-Pacific Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific Vascular Patches Market Share (%), By Country, 2017-2031F
• Figure 101. India Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 102. India Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 103. India Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 104. India Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 105. India Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 106. China Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 107. China Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 108. China Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 109. China Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 110. China Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 112. Japan Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 113. Japan Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 114. Japan Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 115. Japan Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 117. Australia Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 118. Australia Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 119. Australia Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 120. Australia Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 122. Vietnam Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 123. Vietnam Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 124. Vietnam Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 125. Vietnam Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 127. South Korea Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 128. South Korea Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 129. South Korea Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 130. South Korea Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 132. Indonesia Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 133. Indonesia Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 134. Indonesia Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 135. Indonesia Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 137. Philippines Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 138. Philippines Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 139. Philippines Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 140. Philippines Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 142. Middle East & Africa Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 143. Middle East & Africa Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 144. Middle East & Africa Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 145. Middle East & Africa Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa Vascular Patches Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 148. Saudi Arabia Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 149. Saudi Arabia Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 150. Saudi Arabia Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 151. Saudi Arabia Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 153. UAE Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 154. UAE Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 155. UAE Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 156. UAE Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa Vascular Patches Market, By Value, in USD Million, 2017-2031F
• Figure 158. South Africa Vascular Patches Market, By Volume, in Million Units, 2017-2031F
• Figure 159. South Africa Vascular Patches Market Share (%), By Material Type, 2017-2031F
• Figure 160. South Africa Vascular Patches Market Share (%), By Application, 2017-2031F
• Figure 161. South Africa Vascular Patches Market Share (%), By End-user, 2017-2031F
• Figure 162. By Material Type Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 163. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 164. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
• Figure 165. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Global vascular patches market is projected to witness a CAGR of 6.97% during the forecast period 2024-2031F, growing from USD 507.68 million in 2023 to USD 870.12 million in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Vascular patches are used to treat aneurysms, arterial stenosis, and undesirable blood clots, in addition to reconstructing tissue or arteries in cardiovascular illnesses. Heart arteries (coronary arterial bypass), kidneys, legs (femoropopliteal bypass), and the abdominal aorta are the usual surgical sites. The increasing global prevalence of cardiovascular disorders is driving the growth of the vascular patches market. This aspect is reinforced by the rising global tobacco and smoking rates, which indicate a shift in stress levels and changing lifestyles. The market is driven by the aging population's increased vascular problems, the expansion of healthcare facilities, favorable reimbursement policies for treatments connected to these conditions, and the growing usage of biological patches. Vascular patches are also becoming more common because it is more expensive to create a healthcare infrastructure. Vascular patches are in high demand due to the high frequency of ischemic heart disease and stroke, both of which result in a significant number of hospital admissions. Furthermore, it is projected that the vascular patch market will grow a bit more slowly throughout the forecast period due to the decline in carotid endarterectomy surgeries.

For instance, owing to rising demand, Getinge AB expanded the production of premium vascular grafts in May 2022. The company's French facility has doubled its manufacturing capacity.

Growing Adoption of Regenerative Medicine to Fuel Market Growth

The growing use of regenerative medicine is the main factor propelling the market for vascular patches worldwide. Vascular patches are essential to the science of regenerative medicine, which is a game-changer in tissue repair and replacement. Regenerative medicine, which attempts to use the body's inherent healing capacity for tissue repair, is a major paradigm change in healthcare. This method shows promising results in treating several illnesses, such as heart problems, orthopedic injuries, and trauma-related tissue rebuilding. Vascular patches are essential to regenerative medicine since they act as biological scaffolds to direct cell development and differentiation. These patches are crucial in many different types of regenerative therapies because they foster natural tissue regeneration. Regenerative medicine has focused a lot of attention on the heart because of its restricted ability to regenerate. After myocardial infarctions, vascular patches have been effectively used in cardiac regeneration operations to help restore damaged heart tissues. Cardiovascular illnesses continue to be a major worldwide health concern; hence, regenerative medicine and vascular patches are anticipated to become more popular.

In addition, regenerative medicine shows results in treating orthopedic disorders such as injured ligaments and cartilage. Due to its reputation of supporting the tissue healing process, vascular patches are being used more frequently in orthopedic regenerative therapies. The need for these patches in orthopaedics is expected to increase as the population ages and musculoskeletal diseases become more common. Vascular patches have significantly improved skin regeneration and wound care. These patches encourage tissue regeneration by strengthening the body's inherent healing mechanisms, which may lessen problems and scarring. The market for vascular patches is expected to increase even more as regenerative medicine becomes more widely used in wound treatment. Regenerative medicine can shorten recovery times following surgery and gives hope to patients who may be suffering from any chronic illnesses. The goal of using vascular patches in surgical operations is to promote faster patient recovery, reduce problems, and improve tissue healing.

For instance, the S300X, which Lynxter revealed in November 2022, was hailed as a game-changing advancement in elastomer 3D printing technology. The strongest alternative available in the market right now for printing industrial and medical-grade silicones and polyurethanes is the S300X. Its integrated printed support technology has made it possible to print shapes that were previously unprintable. The S300X is a sturdy, compact, industrial tool that is perfect for creating customized masking parts for post-processing (painting, sanding, plasma treatment, etc.), as well as dampers, seals, orthoses that are approved for skin contact, and textiles with extra functionality.

In the same time frame, EPLUS 3D unveiled a state-of-the-art, nine-laser metal 3D printer. The first metal 3D printer company, EPLUS 3D, has formally announced the release of their large-format, multi-laser metal additive manufacturing system. The new machine, which has an in-built envelope of 1258 x 1258 x 1350 mm3 and NINE laser systems, will considerably boost the capacity for developing multi-meter metallic parts and attain the greatest levels of productivity and reliability. This marks the beginning of a new age in additive manufacturing. In terms of materials, the system can work with a variety of metal powders, including those based on titanium, aluminum, and nickel as well as stainless steel, maraging steel, chrome cobalt alloys, and other materials.

Advancements in Surgical Techniques Leading to Market Expansion

The market for vascular patches is expanding significantly on a global scale due to continuous improvements and developments in surgical methods. These developments have paved the way for novel applications of vascular patches in a variety of medical disciplines, increasing their use in surgical procedures across the globe. With its less invasive techniques, smaller incisions, and faster patient recoveries, minimally invasive surgery (MIS) has completely changed the way medicine is practiced. Vascular patches reduce patient discomfort and provide better tissue regeneration and healing in conjunction with MIS methods. Since vascular patches are compatible with MIS, surgeons and patients are favoring them more, which makes them appealing in the surgical environment. The goal of precision surgery is to get the best possible results by using sophisticated procedures and paying close attention to accuracy and detail. Vascular patches are essential for precision surgery because they improve tissue mending, lower surgical complexities and speed up the healing process. The assimilation of these devices into surgical operations in diverse medical disciplines leads to improved surgical results and faster patient recuperation.

Vascular patches are now a vital tool in cardiovascular surgery for healing injured heart tissues and speeding the recovery process. The growing need for vascular patches further solidifies their significance in cardiovascular treatments as surgical techniques in cardiology, particularly the adoption of minimally invasive approaches, advance. Vascular patches are useful in orthopedic surgery for treatments including joint replacement, arthroscopy, and fracture repair because they promote tissue regeneration and recovery. Vascular patches are becoming a more important tool for optimizing surgical techniques and improving patient outcomes as orthopedic surgery advances. These patches are essential for tissue healing and natural-looking outcomes in aesthetic and reconstructive surgery, especially in cases like breast and facial reconstruction. The need for vascular patches in these treatments is further driven by the ongoing advancements in aesthetic surgery techniques. Vascular patches facilitate tissue restoration by creating an environment that is favorable for the process. The market is growing because surgeons from various disciplines are incorporating vascular patches into surgical procedures at an increasing rate.

For instance, Vivasure Medical Ltd. led a series D funding round in May 2022 in which the company closed the first tranche of USD 22 million. With this funding, the business hopes to gain regulatory approval in the United States and Europe for its portfolio of large-bore, patch-based, entirely absorbable percutaneous vessel closure devices used in transcatheter endovascular and cardiovascular surgeries.

Increasing Dominance of Aortic Aneurysm Positively Impacts the Market

Over the course of the forecast period, the vascular patches market is anticipated to have significant growth in the aortic aneurysm sector. The growing number of elderly people, the increasing burden of vascular illnesses like atherosclerosis, and the rising demand for minimally invasive procedures are the main growth drivers in this segment. Aortic aneurysms are balloon-like bulges in the aorta, the main artery that travels through the chest and body to carry blood from the heart. An ascending aortic pseudoaneurysm is an uncommon but potentially deadly complication following heart surgery that may burst. Patch repair is frequently used in place of replacing a tube graft for treating a tiny, localized saccular pseudoaneurysm of the aorta. One of the main drivers responsible for expanding this market is the rise in incidences of atherosclerosis and aortic aneurysms. For example, data released in April 2022 by National Health Services (NHS) United Kingdom indicates that around 1,542 cases of aneurysms were documented in the United Kingdom in 2021. Furthermore, vascular disorders are becoming more common in the aging population, which is also causing the segment to rise. Due to the growing elderly population, the market is expected to grow rapidly over the forecast period.

North America to Dominate the Vascular Patches Market

Over the course of the forecast period, North America is anticipated to have a sizable share of the global vascular patch market due to factors including the rising prevalence of vascular disorders. Furthermore, the United States is experiencing an increase in healthcare expenditure, which opens new avenues for the development of improved vascular patches and makes them more widely available, spurring market expansion. According to the organization of economic cooperation and development (OECD) data, healthcare spending in the United States in June 2022 was 17.8% of the nation's overall GDP in 2021. It is anticipated that the region's growing funding for atherosclerosis will quicken the development of vascular patches and sharpen the company's focus on creating cutting-edge products, which will spur market expansion. For example, May 2022 data from the National Institute of Health (NIH) indicates that approximately USD 413 million was granted for atherosclerosis in 2021. Approximately USD 430 million was allocated in 2022 for research and studies related to the condition, and it was anticipated that this funding would increase to USD 432 million by 2023. Additionally, the increasing incidence of cardiovascular diseases and accompanying conditions like diabetes raise the risk of stroke, cerebrovascular disease, and other conditions that need surgery, supporting the market's expansion. For example, according to estimates made by the International Diabetes Federation (IDF) in 2022, 14.1 million people in Mexico had diabetes in 2021 and by 2030, this figure is expected to rise to 17 million, and by 2045, it is expected to reach 21.1 million. The same source states that approximately 32 million Americans and 2.9 million Canadians had diabetes in 2021, and this figure is expected to rise to 36.2 million and 3.4 million, respectively, by 2045. Thus, there may be a greater need for cardiac procedures because of the rising incidences of diabetes-related cardiovascular problems. This is expected to drive the demand for vascular patches, supporting market expansion.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the vascular patches market is the increasing prevalence of chronic diseases and vascular disorders. Not only this, but the rising population and sedentary lifestyles are also factors that will always propel market growth in the future. Given that technology is advancing, cutting-edge technology can also be expected in this area also. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, the Teijin Limited, Fukui Tateami Co., Ltd., and Osaka Medical and Pharmaceutical University consortium recently announced that Teijin Medical Technologies Co., Ltd., a Teijin Group company, will begin manufacturing and distributing a novel surgical patch on June 12, 2024. The patch will be marketed under the brand name SYNFOLIUM.

Key Players Landscape and Outlook

Several companies, such as Baxter International, Inc., LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., Getinge AB, B. Braun Medical Ltd., Edwards Lifesciences Corporation, Becton, Dickinson and Company, Terumo Corporation, Artivion, Inc., and Labcor Laboratorios, etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launch of newly developed vascular patches, to help researchers to strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

In 2022, Labcor Laboratorios Research Centre received ISO 9001 certification for its technical development of experimental cardiovascular and vascular operations.

Medical technology company, Haemonetics Corporation announced on September 12, 2022, that it had obtained CE mark certification for its VASCADE venous vascular closure and VASCADE MVP vascular closure systems.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Vascular Patches Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Material Type
  • 4.2.1. Biologic Vascular Patches
  • 4.2.2. Synthetic Vascular Patches
• 4.3. By Application
  • 4.3.1. Carotid Endarterectomy
  • 4.3.2. Open Repair of Aortic Vascular Aneurysm
  • 4.3.3. Vascular Bypass Surgery
  • 4.3.4. Congenital Heart Disease
  • 4.3.5. Profundaplasty
  • 4.3.6. Others
• 4.4. By End-user
  • 4.4.1. Hospitals
  • 4.4.2. Ambulatory Surgical Centers
  • 4.4.3. Trauma Care Centers
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia-Pacific
  • 4.5.4. South America
  • 4.5.5. Middle East and Africa
• 4.6. By Company Market Share (%), 2023

5. Global Vascular Patches Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Material Type
    • 5.1.2.1. Biologic Vascular Patches
    • 5.1.2.2. Synthetic Vascular Patches
  • 5.1.3. By Application
    • 5.1.3.1. Carotid Endarterectomy
    • 5.1.3.2. Open Repair of Aortic Vascular Aneurysm
    • 5.1.3.3. Vascular Bypass Surgery
    • 5.1.3.4. Congenital Heart Disease
    • 5.1.3.5. Profundaplasty
    • 5.1.3.6. Others
  • 5.1.4. By End-user
    • 5.1.4.1. Hospitals
    • 5.1.4.2. Ambulatory Surgical Centers
    • 5.1.4.3. Trauma Care Centers
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
    • 5.1.5.2. By Material Type
      • 5.1.5.2.1. Biologic Vascular Patches
      • 5.1.5.2.2. Synthetic Vascular Patches
    • 5.1.5.3. By Application
      • 5.1.5.3.1. Carotid Endarterectomy
      • 5.1.5.3.2. Open Repair of Aortic Vascular Aneurysm
      • 5.1.5.3.3. Vascular Bypass Surgery
      • 5.1.5.3.4. Congenital Heart Disease
      • 5.1.5.3.5. Profundaplasty
      • 5.1.5.3.6. Others
    • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Ambulatory Surgical Centers
      • 5.1.5.4.3. Trauma Care Centers
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. Asia-Pacific
  • 5.3.1. India
  • 5.3.2. China
  • 5.3.3. Japan
  • 5.3.4. Australia
  • 5.3.5. Vietnam
  • 5.3.6. South Korea
  • 5.3.7. Indonesia
  • 5.3.8. Philippines
• 5.4. South America
  • 5.4.1. Brazil
  • 5.4.2. Argentina
• 5.5. Middle East and Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. South Africa

6. Market Mapping, 2023

• 6.1. By Material Type
• 6.2. By Application
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Demand Supply Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat From New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Regulatory Approvals
• 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Baxter International, Inc.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products and Services
  • 13.1.4. Financials (As Reported)
  • 13.1.5. Key Market Focus and Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. LeMaitre Vascular, Inc.
• 13.3. W. L. Gore & Associates, Inc.
• 13.4. Getinge AB
• 13.5. B. Braun Medical Ltd.
• 13.6. Edwards Lifesciences Corporation
• 13.7. Becton, Dickinson and Company
• 13.8. Terumo Corporation
• 13.9. Artivion, Inc.
• 13.10. Labcor Laboratorios

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer